11例腹腔镜脾肿瘤切除术的疗效分析

Efficacy analysis of laparoscopic splenectomy for primary splenic tumor with 11 case reports

目的探讨腹腔镜脾切除术治疗脾原发肿瘤的安全性与有效性。方法回顾性分析我院2009年7月至2013年12月行腹腔镜睥切除术治疗脾肿瘤的临床资料，研究其手术安全性及术后恢复情况。结果共11例脾肿瘤患者行腹腔镜脾切除术，平均年龄57岁，其中女性6例（54．5％）。1例因脾门大出血中转开腹。平均手术时间（131．8±12．1）分，平均出血（49．1±52．2）ml，平均切口长度（5．2±0.5）cm，平均住院时间（5．7±0．6）天。术后病理示5例良性、6例恶性。平均随访22（2～53）个月，无远处转移，无戳孔／切口和局部复发。结论腹腔镜脾切除术治疗脾良恶性肿瘤安全可行。

Objective To explore the feasibility and safety of laparoscopic splenectomy （KS） for primary splenic tumor. Method A retrospective study of patients with primary, splenic tumor, who underwent a KS between July 2009 and December 2013 was performed. The safety of operation, status of recovery, and complications were summarized. Result 11 patients underwent KS for solid splenic tumor between July 2009 and December 2013. Mean age was 57 years and 54. 5% （6/11） were females. One case was converted to open surgery due to massive bleeding of splenic hilum. The average operation time was （ 131. 8± 12. 1 ） rain, mean blood loss was （49. 1±52. 2） ml, average incision length was （5.2±0. 5） cm, and the average time for hospitalization was （5. 7±0. 6） days. Pathology revealed 5 patients with benign tumors and 6 with malignant tumors. The average follow-up time was 22 （2-53） months. There were no distant metastases and no pert-site or local reeun＇ence during follow-up. Conclusion Laparoseopic spleneetomy is feasible and safe for treatment of both benign and malignant tumors of the spleen.